Skip to main content
Origin Life Sciences, Inc. (OLSI)
Origin Life Sciences will go public soon, but the exact IPO date is still unknown.
IPO Price
$4.00
Shares Offered
1,875,000
Deal Size
$7.50M

Origin Life Sciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year
 20222021
Net Income
-8.84-6.33
Depreciation & Amortization
0.090.09
Share-Based Compensation
0.083.1
Other Operating Activities
7.312.22
Operating Cash Flow
-1.36-0.92
Share Issuance / Repurchase
0.330.55
Debt Issued / Paid
1.580.18
Financing Cash Flow
1.910.73
Net Cash Flow
0.55-0.19
Free Cash Flow
-1.36-0.92
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).